These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 22466288)

  • 21. Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner.
    Gauthier K; Billon C; Bissler M; Beylot M; Lobaccaro JM; Vanacker JM; Samarut J
    J Biol Chem; 2010 Sep; 285(36):28156-63. PubMed ID: 20615868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The transcription factor ChREBP: a key modulator of insulin sensitivity?].
    Benhamed F; Poupeau A; Postic C
    Med Sci (Paris); 2013; 29(8-9):765-71. PubMed ID: 24005632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
    Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
    Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.
    Boergesen M; Poulsen Ll; Schmidt SF; Frigerio F; Maechler P; Mandrup S
    J Biol Chem; 2011 Apr; 286(15):13214-25. PubMed ID: 21282101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity.
    Morigny P; Houssier M; Mairal A; Ghilain C; Mouisel E; Benhamed F; Masri B; Recazens E; Denechaud PD; Tavernier G; Caspar-Bauguil S; Virtue S; Sramkova V; Monbrun L; Mazars A; Zanoun M; Guilmeau S; Barquissau V; Beuzelin D; Bonnel S; Marques M; Monge-Roffarello B; Lefort C; Fielding B; Sulpice T; Astrup A; Payrastre B; Bertrand-Michel J; Meugnier E; Ligat L; Lopez F; Guillou H; Ling C; Holm C; Rabasa-Lhoret R; Saris WHM; Stich V; Arner P; Rydén M; Moro C; Viguerie N; Harms M; Hallén S; Vidal-Puig A; Vidal H; Postic C; Langin D
    Nat Metab; 2019 Jan; 1(1):133-146. PubMed ID: 32694809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Carbohydrate Response Element-Binding Protein Beta (ChREBPβ) and Thioredoxin Interacting Protein (TXNIP) Levels in Human Adipocytes Differentiated in High Glucose Concentrations.
    Peshdary V; Gagnon A; Landry A; Ma L; Sorisky A
    Can J Diabetes; 2019 Apr; 43(3):215-220. PubMed ID: 30551936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes.
    Stoeckman AK; Ma L; Towle HC
    J Biol Chem; 2004 Apr; 279(15):15662-9. PubMed ID: 14742444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
    Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
    J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T3 and Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in Brown Adipocytes From Male Mice.
    Katz LS; Xu S; Ge K; Scott DK; Gershengorn MC
    Endocrinology; 2018 Jan; 159(1):557-569. PubMed ID: 29077876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
    Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C
    J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity.
    Hurtado del Pozo C; Vesperinas-García G; Rubio MÁ; Corripio-Sánchez R; Torres-García AJ; Obregon MJ; Calvo RM
    Biochim Biophys Acta; 2011 Dec; 1811(12):1194-200. PubMed ID: 21840420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells.
    Bagchi DP; Nishii A; Li Z; DelProposto JB; Corsa CA; Mori H; Hardij J; Learman BS; Lumeng CN; MacDougald OA
    Mol Metab; 2020 Dec; 42():101078. PubMed ID: 32919095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.
    Song Z; Yang H; Zhou L; Yang F
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic glucose sensing is required to preserve β cell glucose competence.
    Seyer P; Vallois D; Poitry-Yamate C; Schütz F; Metref S; Tarussio D; Maechler P; Staels B; Lanz B; Grueter R; Decaris J; Turner S; da Costa A; Preitner F; Minehira K; Foretz M; Thorens B
    J Clin Invest; 2013 Apr; 123(4):1662-76. PubMed ID: 23549084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importin-alpha protein binding to a nuclear localization signal of carbohydrate response element-binding protein (ChREBP).
    Ge Q; Nakagawa T; Wynn RM; Chook YM; Miller BC; Uyeda K
    J Biol Chem; 2011 Aug; 286(32):28119-27. PubMed ID: 21665952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
    Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
    J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
    Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
    PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
    Iizuka K; Miller B; Uyeda K
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.